Research & Development World

  • R&D World Home
  • Topics
    • Aerospace
    • Automotive
    • Biotech
    • Careers
    • Chemistry
    • Environment
    • Energy
    • Life Science
    • Material Science
    • R&D Management
    • Physics
  • Technology
    • 3D Printing
    • A.I./Robotics
    • Software
    • Battery Technology
    • Controlled Environments
      • Cleanrooms
      • Graphene
      • Lasers
      • Regulations/Standards
      • Sensors
    • Imaging
    • Nanotechnology
    • Scientific Computing
      • Big Data
      • HPC/Supercomputing
      • Informatics
      • Security
    • Semiconductors
  • R&D Market Pulse
  • R&D 100
    • Call for Nominations: The 2025 R&D 100 Awards
    • R&D 100 Awards Event
    • R&D 100 Submissions
    • Winner Archive
    • Explore the 2024 R&D 100 award winners and finalists
  • Resources
    • Research Reports
    • Digital Issues
    • R&D Index
    • Subscribe
    • Video
    • Webinars
  • Global Funding Forecast
  • Top Labs
  • Advertise
  • SUBSCRIBE

WHO Says A Billion Infected With Neglected Diseases

By R&D Editors | October 14, 2010

GENEVA (AP) – The World Health Organization estimated that 1 billion of the world’s poorest people suffer from neglected tropical diseases such as dengue, rabies and leprosy that remain concentrated in remote rural areas and urban slums despite being mostly eradicated from large areas of the world.

WHO said it can substantially reduce those numbers with the help of drug donations from the pharmeceutical industry, which announced fresh pledges.

WHO identified 17 diseases and disease groups present in 149 countries one-third of the 2.7 billion people living on less than $2 a day. Thirty countries have six or more of the diseases. In all, more than one-third of the 2.7 billion people living on less than $2 a day are affected.

“They cause massive but hidden and silent suffering, and frequently kill, but not in the numbers comparable to the deaths caused by HIV/AIDs, tuberculosis or malaria,” said WHO director general Margaret Chan.

Still, Chan said that the diseases take a serious toll that serves to “anchor large populations in poverty.”

Two of the diseases, onchocerciasis, known as river blindness, and trachoma, a bacterial eye infection, cause blindness. Leprosy and lymphatic filariasis, or elephantiasis, leave victims deformed, hamper productivity and normal social interaction, Chan said. Sleeping sickness, or human African trypanosomiasis, debilitates before it kills. Left untreated, rabies is fatal.

Novartis has renewed a commitment to donate drugs to treat leprosy, while GlaxoSmithKline said it would expand donations of a drug to treat worm infections and Sanofi-Aventis will continue its support to help eliminate sleeping sickness and other illness.

Also active in the fight are Bayer, Eisai and Johnson&Johnson, WHO said.

The stigma was especially hard on girls and women. “Many neglected tropical diseases cause disfigurement and disability, leading to stigma and social discrimination,” diminishing marriage prospects and raising the likelihood of abandonment for women and girls, the report said.

Diseases like dengue don’t garner the same sort of international response because the victims lack a political voice, and the diseases don’t tend to spread to distant countries and only rarely affect travelers, the report said.

Among the strategies to control the neglected tropical diseases are expanding preventative chemotherapy, which means treating whole populations where such diseases are identified with drugs that may knock out several of the diseases at once.

The report also recommends doing a better job of identifying the diseases, improving sanitation and controlling insects and animals, which can spread the diseases into human populations.

Chan said the campaign is aimed at making a “deliberate effort” to eradicate the diseases as a means to alleviate poverty, rather than waiting for them to “gradually disappear as countries develop.”

Date: October 13, 2010
Source: Associated Press

Related Articles Read More >

Eli Lilly facility
9 R&D developments this week: Lilly builds major R&D center, Stratolaunch tests hypersonic craft, IBM chief urges AI R&D funding
professional photo of wooly mammoth in nature --ar 2:1 --personalize sq85hce --v 6.1 Job ID: 47185eaa-b213-4624-8bee-44f9e882feaa
Why science ethicists are sounding skepticism and alarm on ‘de-extinction’
ALAFIA system speeds complex molecular simulations for University of Miami drug research
3d rendered illustration of the anatomy of a cancer cell
Funding flows to obesity, oncology and immunology: 2024 sales data show where science is paying off
rd newsletter
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest info on technologies, trends, and strategies in Research & Development.
RD 25 Power Index

R&D World Digital Issues

Fall 2024 issue

Browse the most current issue of R&D World and back issues in an easy to use high quality format. Clip, share and download with the leading R&D magazine today.

Research & Development World
  • Subscribe to R&D World Magazine
  • Enews Sign Up
  • Contact Us
  • About Us
  • Drug Discovery & Development
  • Pharmaceutical Processing
  • Global Funding Forecast

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search R&D World

  • R&D World Home
  • Topics
    • Aerospace
    • Automotive
    • Biotech
    • Careers
    • Chemistry
    • Environment
    • Energy
    • Life Science
    • Material Science
    • R&D Management
    • Physics
  • Technology
    • 3D Printing
    • A.I./Robotics
    • Software
    • Battery Technology
    • Controlled Environments
      • Cleanrooms
      • Graphene
      • Lasers
      • Regulations/Standards
      • Sensors
    • Imaging
    • Nanotechnology
    • Scientific Computing
      • Big Data
      • HPC/Supercomputing
      • Informatics
      • Security
    • Semiconductors
  • R&D Market Pulse
  • R&D 100
    • Call for Nominations: The 2025 R&D 100 Awards
    • R&D 100 Awards Event
    • R&D 100 Submissions
    • Winner Archive
    • Explore the 2024 R&D 100 award winners and finalists
  • Resources
    • Research Reports
    • Digital Issues
    • R&D Index
    • Subscribe
    • Video
    • Webinars
  • Global Funding Forecast
  • Top Labs
  • Advertise
  • SUBSCRIBE